Monday, 26 Aug 2019

Autoimmune/Lupus

Date Typesort ascending Title Save
30 Dec 2017 Social RT @lupuscyclopedia: Check out my book - 'The Lupus Encyclopedia: A Comprehensive Guide for Patients and Families (A ...' - on #BookBuzz -…
28 Apr 2018 Social Study of 537 GCA pts undergoing temporal artery bx shows the value of CBC elements in predicting a +Bx: Thrombocytosis (OR 4.44), NLR (OR 1.81), PLR (OR 3.25), CRP (OR 3.00), ESR (OR 3.62), increased age (OR 1.03) https://t.co/3XvzBR5cEh
12 Oct 2018 Social SLE Study of 77 persistent ED users (1143 encounters) vs 52 limited ED (335) finds Pain-related ED visits more common w/ persistent users (32%) than limited (18%). Persistent users with pain encounters were more obese, with fewer comorbid, be on LTOT. https://t.co/ApUjIxcZXw
19 Oct 2017 Social Deaths from catastrophic APS is down from 50% to 37% with earlier Dx and Rx. #APLAR2017 https://t.co/FWUA3vItri
13 Sep 2016 Social Nice readable review of pathophysiology and treatment of #Lupus nephritis. https://t.co/nWdERulHKy
28 Mar 2016 Social Incidence of Herpes Zoster (shingles) for RA & SLE pts ≥40 yrs is 1.5-2 times higher than gen pop (8.5/1000) https://t.co/4PYhc35c6L
30 Apr 2017 Social RT @DrRachelTate: Immunosuppressive therapy importance/use still to be determined. Potential MOAs. Dr. Erkan @RheumNow #SOTA2017 https://t.…
09 Feb 2019 Social The RHeumNow Podcast is up! Alot on lupus this time. View here: https://t.co/fIq9qOFRW6 or listen to podcast on iTunes, Apple Car Play Podcasts or on SoundCloud https://t.co/wtmkKEsqCX
08 Jan 2018 Social RT @DrPetryna: Pivotal Ph3 52 wk NE Asia multi-center trial of belimumab in SLE pts reveals significantly improved SRI (53.8% Bel vs 40.1%…
27 Dec 2016 Social 10% of ANCA+ vasculitis developed cancer; CTX had 3x risk; RTX had 33% lower risk. CA was 4.6x more w/ CTX than RTX https://t.co/RJv9OwhSB9
05 Nov 2017 Social RT @doctorakerkar: Pathology driven treatment protocol for #Lupus nephritis #ACR17 @rheumnow https://t.co/6euyeP56cS
07 Nov 2017 Social RT @_connectedcare: ANA as a screening test is problematic given this low specificity. Leads to so much anxiety #ACR17 @RheumNow https://t.…
23 Jan 2018 Social Among 286 SLE from the NHS, 42% were dsDNA+ at diagnosis. Current smokers were more likely to be dsDNA+ (HR 1.86) & >10 Pk-yr hx had elevated dsDNA+ SLE risk (HR 1.60) https://t.co/0RSI7r3zWP
16 Jan 2017 Social small-molecule inhibitor CCG-203971 blocks nuclear localization & activity of MRTF-A; a potentail future Rx for PSS. https://t.co/E5SWatZwpy
05 Nov 2017 Social RT @DrRachelTate: Pre-clinical assoc between serologic measures of EBV reactivation and SLE disease transition. #ACR17 @RheumNow #910 https…
18 May 2017 Social 189 SLE pts F/U for 13yrs; 53-59% lower risk of CV events if on ASA &HCQ, but APL Ab+ or HTN incr CV risk 18 fold https://t.co/O5PAOjIyv3
08 Jul 2016 Social Majority of pediatric lupus w/ acute pancreatitis develop macrophage activation syndr w/ high mortality rate https://t.co/m6i4iWynmz
23 Jul 2015 Social Apremilast useful in lupus? 8pt open label trial in discoid LE showed significant skin improvement @ 85d (by CLASI) http://t.co/v7iCv5H7zq
25 Oct 2018 Social RT @CCalabreseDO: checkpoint inhibitor-related myositis associated with poor outcomes. #2976 @RheumNow @HealioRheum #ACR18
02 Nov 2015 Social Uncontrolled trial of Perfenidone (antifibrotic) gel in 12 pts w/ localized scleroderma shows major skin benefits https://t.co/b2myM0uZVv